Cargando…
Identification and validation of a PD-L1-related signature from mass spectrometry in gastric cancer
BACKGROUND: According to the guidelines, PD-L1 expression is a critical indicator for guiding immunotherapy application. According to certain studies, regardless of PD-L1 expression, immunotherapy could be advantageous for individuals with gastric cancer. Therefore, new scoring systems or biomarkers...
Autores principales: | Chen, Xiancong, Mao, Deli, Li, Dongsheng, Li, Wenchao, Wei, Hongfa, Deng, Cuncan, Chen, Hengxing, Zhang, Changhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356661/ https://www.ncbi.nlm.nih.gov/pubmed/36592213 http://dx.doi.org/10.1007/s00432-022-04529-6 |
Ejemplares similares
-
Cross-Talk of Focal Adhesion-Related Gene Defines Prognosis and the Immune Microenvironment in Gastric Cancer
por: Mao, Deli, et al.
Publicado: (2021) -
Syntaxin-6, a Reliable Biomarker for Predicting the Prognosis of Patients with Cancer and the Effectiveness of Immunotherapy
por: Li, Wenchao, et al.
Publicado: (2022) -
Construction of a hypoxia-immune-related prognostic panel based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer
por: Deng, Cuncan, et al.
Publicado: (2023) -
Gastric cancer clinical characteristics and their altered trends in South China: An epidemiological study with 2,800 cases spanning 26 years
por: Wei, Hongfa, et al.
Publicado: (2023) -
Comprehensive analysis to construct a novel immune-related prognostic panel in aging-related gastric cancer based on the lncRNA‒miRNA-mRNA ceRNA network
por: Deng, Cuncan, et al.
Publicado: (2023)